 Tissue Extracts
"Tissue Extracts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Preparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions.
| Descriptor ID |
D014020
|
| MeSH Number(s) |
D20.777
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tissue Extracts".
Below are MeSH descriptors whose meaning is more specific than "Tissue Extracts".
This graph shows the total number of publications written about "Tissue Extracts" by people in this website by year, and whether "Tissue Extracts" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 | | 2001 | 0 | 2 | 2 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Tissue Extracts" by people in Profiles.
-
Shrestha RT, Malabanan A, Haugen BR, Levy EG, Hennessey JV. ADVERSE EVENT REPORTING IN PATIENTS TREATED WITH THYROID HORMONE EXTRACT. Endocr Pract. 2017 May; 23(5):566-575.
-
Crawford ED, Petrylak DP, Higano CS, Kibel AS, Kantoff PW, Small EJ, Shore ND, Ferrari A. Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer. Can J Urol. 2015 Dec; 22(6):8048-55.
-
Crawford ED, Higano CS, Shore ND, Hussain M, Petrylak DP. Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies. J Urol. 2015 Dec; 194(6):1537-47.
-
Grzywa R, Burchacka E, Lecka M, Winiarski L, Walczak M, Lupicka-Slowik A, Wysocka M, Burster T, Bobrek K, Csencsits-Smith K, Lesner A, Sienczyk M. Synthesis of novel phosphonic-type activity-based probes for neutrophil serine proteases and their application in spleen lysates of different organisms. Chembiochem. 2014 Nov 24; 15(17):2605-12.
-
Beer TM, Schellhammer PF, Corman JM, Glod? LM, Hall SJ, Whitmore JB, Frohlich MW, Penson DF. Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancer. Urology. 2013 Aug; 82(2):410-5.
-
Bosque PJ, Boyer PJ, Mishra P. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration. PLoS One. 2013; 8(5):e62301.
-
Rudolph MC, Karl Maluf N, Wellberg EA, Johnson CA, Murphy RC, Anderson SM. Mammalian fatty acid synthase activity from crude tissue lysates tracing ??C-labeled substrates using gas chromatography-mass spectrometry. Anal Biochem. 2012 Sep 15; 428(2):158-66.
-
Crawford ED, Flaig TW. Optimizing outcomes of advanced prostate cancer: drug sequencing and novel therapeutic approaches. Oncology (Williston Park). 2012 Jan; 26(1):70-7.
-
Beer TM, Bernstein GT, Corman JM, Glode LM, Hall SJ, Poll WL, Schellhammer PF, Jones LA, Xu Y, Kylstra JW, Frohlich MW. Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancer. Clin Cancer Res. 2011 Jul 01; 17(13):4558-67.
-
Weber RW. Potency variability in diagnostic allergen extracts: is there an optimal strength? Ann Allergy Asthma Immunol. 2011 May; 106(5):353-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|